The Journal of Immunology, Vol 146, Issue 10 3431-3436, Copyright © 1991 by American Association of Immunologists

ARTICLES

IL-1 expression in human monocytes is transcriptionally and posttranscriptionally regulated by IL-4

RP Donnelly, MJ Fenton, JD Kaufman and TL Gerrard
Division of Cytokine Biology, Food and Drug Administration, Bethesda, MD 20892.

The T cell-derived lymphokine, IL-4, inhibits production of IL-1 beta by normal human monocytes. To determine whether IL-4 suppresses IL-1 expression by a transcriptional and/or posttranscriptional mechanism, we evaluated the half-life of LPS-induced IL-1 beta message and transcriptional rate of the pro-IL-1 beta gene in human monocytes after treatment with IL-4. Although the initial steady-state IL-1 mRNA levels in control and IL-4-treated monocytes were comparable during the first 2 h after stimulation with LPS, IL-1 message levels subsequently decreased at a significantly greater rate in the IL-4-treated cells. Thus, IL-4 did not prevent the initial expression of IL-1 message, but did accelerate down-regulation of IL-1 mRNA in LPS-stimulated monocytes. The initial 2 to 3 h lag period may be necessary for production of a protein(s) that mediates this inhibitory effect because treatment with the protein synthesis inhibitor, cycloheximide, blocked the marked reduction of IL-1 message levels induced by IL-4. Nuclear run-on analyses demonstrated that IL-4 decreases IL-1 mRNA levels, in part, by repressing IL-1 gene transcription. Furthermore, mRNA half- life studies showed that IL-4 also significantly increases the rate of IL-1 message turnover in these cells. Together, these findings demonstrate that IL-4 inhibits IL-1 production in human monocytes by suppressing the formation of new IL-1 transcripts as well as by decreasing IL-1 message stability. In addition, the kinetics of inhibition and the fact that cycloheximide blocks this process suggest that IL-4 induces or enhances synthesis of a protein(s) that mediates these effects.

This article has been cited by other articles:

				D. Church, S. Elsayed, O. Reid, B. Winston, and R. Lindsay Burn Wound Infections Clin. Microbiol. Rev., April 1, 2006; 19(2): 403 - 434. [Abstract] [Full Text] [PDF]

				R. Thieringer, C. B. Le Grand, L. Carbin, T.-Q. Cai, B. Wong, S. D. Wright, and A. Hermanowski-Vosatka 11{{beta}}-Hydroxysteroid Dehydrogenase Type 1 Is Induced in Human Monocytes upon Differentiation to Macrophages J. Immunol., July 1, 2001; 167(1): 30 - 35. [Abstract] [Full Text] [PDF]

				S. Marecki, C. J. Riendeau, M. D. Liang, and M. J. Fenton PU.1 and Multiple IFN Regulatory Factor Proteins Synergize to Mediate Transcriptional Activation of the Human IL-1{{beta}} Gene J. Immunol., June 1, 2001; 166(11): 6829 - 6838. [Abstract] [Full Text] [PDF]

				H. Sasaki, L. Hou, A. Belani, C.-Y. Wang, T. Uchiyama, R. Muller, and P. Stashenko IL-10, But Not IL-4, Suppresses Infection-Stimulated Bone Resorption In Vivo J. Immunol., October 1, 2000; 165(7): 3626 - 3630. [Abstract] [Full Text] [PDF]

				E. M. Coccia, E. Stellacci, G. Marziali, G. Weiss, and A. Battistini IFN-{gamma} and IL-4 differently regulate inducible NO synthase gene expression through IRF-1 modulation Int. Immunol., July 1, 2000; 12(7): 977 - 985. [Abstract] [Full Text] [PDF]

				M. Bergmann, P. J. Barnes, and R. Newton Molecular Regulation of Granulocyte Macrophage Colony-Stimulating Factor in Human Lung Epithelial Cells by Interleukin (IL)-1beta , IL-4, and IL-13 Involves Both Transcriptional and Post-Transcriptional Mechanisms Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 582 - 589. [Abstract] [Full Text]

				S. C. Morris, W. C. Gause, and F. D. Finkelman IL-4 Suppression of In Vivo T Cell Activation and Antibody Production J. Immunol., February 15, 2000; 164(4): 1734 - 1740. [Abstract] [Full Text] [PDF]

				H. L. Dickensheets, C. Venkataraman, U. Schindler, and R. P. Donnelly Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression PNAS, September 14, 1999; 96(19): 10800 - 10805. [Abstract] [Full Text] [PDF]

				Y. Ohmori and T. A. Hamilton STAT6 Is Required for the Anti-inflammatory Activity of Interleukin-4 in Mouse Peritoneal Macrophages J. Biol. Chem., October 30, 1998; 273(44): 29202 - 29209. [Abstract] [Full Text] [PDF]

				D. A. Horwitz, Hua Wang, and J. D. Gray Cytokine Gene Profile in Circulating Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus: Increased Interleukin-2 but not Interleukin-4 mRNA Lupus, October 1, 1994; 3(5): 423 - 428. [Abstract] [PDF]

				Y. Ohmori and T. A. Hamilton Interleukin-4/STAT6 Represses STAT1 and NF-kappa B-dependent Transcription through Distinct Mechanisms J. Biol. Chem., November 22, 2000; 275(48): 38095 - 38103. [Abstract] [Full Text] [PDF]